Han Sang Kim
연세대학교 의예과 · 의학
한상기 교수의 연구실은 종양 생물학과 정밀의료를 융합한 연구를 중심으로, 방사선 감수성 관련 유전자 및 신호전달 경로 탐색, 암 치료의 개인화를 위한 바이오마커 규명, 그리고 약물 반응성과 관련된 유전적 변이 분석을 수행하고 있습니다. 특히, 신약 후보 물질의 효과를 평가하고 환자의 치료 반응을 예측할 수 있는 분자 기반의 정밀의료 전략 개발에 초점을 맞추고 있습니다. 또한, 만성 통증 관리 및 치료의 질적 향상을 위한 간호사 주도 통증 교육 프로그램의 효과성에 대해서도 연구를 확장하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
Integration of four different microarray experiments and gene selection using gene set analysis discovered possible target genes and pathways relevant to radiosensitivity. Our results suggested that the identified genes are candidates for radiosensitivity biomarkers and that integrin signaling via adhesion molecules could be a target for radiosensitization.
Dacomitinib demonstrated clinical efficacy with manageable toxicity in platinum-failed R/M-SCCHN patients. Screening of PI3K pathway mutation and inflammatory cytokine expression may help identify which R/M-SCCHN patients are likely to gain benefit from dacomitinib.
In recent robotics research, the Stewart platform has been increasingly studied for possible use as a machine tool in view of the advantages of high stiffness and accuracy over serial-type manipulators. In designing and controlling a machine tool, accuracy is one of the most important factors to be considered. This article presents the development of methods of the forward and inverse error bound analyses of the Stewart platform. The forward error bound analysis is used to find the error bound o
Standardized pain education using nursing specialists is an efficient way to improve not only pain itself but also anxiety, depression, performance, and QoL. The addition of telemonitoring helps to improve pain management in the outpatient setting.
Periodontal disease, including periodontitis, was associated with increased risk of cancer, which persisted after controlling for confounding factors. Further prospective research is warranted to establish a causal relationship.
The results suggest that the hypomorphic <i>FTO</i> p.A134T variant is associated with thiopurine-induced leukopenia. These results shed light on the novel physiological role of FTO and provide a potential pharmacogenetic biomarker for thiopurine therapy.
Our findings demonstrate the feasibility of evDNA as a complementary tool to aid current methods of patient evaluation in the diagnosis and surveillance of colon cancer.
MET amplification and Met overexpression were positively correlated in GC. MET status should be re-evaluated in GC patients with liver metastasis, especially for metachronous metastasis.
Consolidation chemotherapy using paclitaxel/carboplatin may be inefficient and relatively toxic to advanced-stage epithelial ovarian cancer patients with complete response to six cycles of the same chemotherapy after surgery.
The presence and size of liver tumors, liver function, and NLR are key factors determining the response to nivolumab in aHCC. These clinical factors should be considered when treating patients with advanced HCC with PD-1 blockade.
Adenocarcinoma arising from the ampulla of Vater is a rare disease and has limited data regarding outcome of chemotherapy. The ampulla of Vater is a heterogeneous junctional structure located at the union of the common bile duct, the pancreatic duct, and the small intestine. Thus, ampullary adenocarcinoma is classified as either intestinal type or pancreatobiliary type. We investigated the efficacy of the XELOX (capecitabine plus oxaliplatin) chemotherapy in patients with recurrent or metastatic